Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
作者信息
Salama Benarroch I, Nano H, Pérez H, Elizalde F, Bisceglia H, Salama A
出版信息
Ophthalmologica. 1977;174(1):47-51. doi: 10.1159/000308575.
PMID:322009
Abstract
In this double-blind, randomized trial, which lasted for 2 years, the authors investigated the efficacy of calcium dobesilate on diabetic retinopathy. 68 patients (51 on the active substance, 17 on placebo) participated in the study. The statistical analysis of the results indicate that calcium dobesilate acts as a potent angioprotector, capable of preventing both intra and extraretinal hemorrhages. The drug also lowers the incidence of exudate formation and improves visual acuity.
摘要
相似文献
1
Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
Ophthalmologica. 1977;174(1):47-51. doi: 10.1159/000308575.
2
The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.羟苯磺酸钙对非增殖性糖尿病视网膜病变的影响：一项对照研究。
Ophthalmology. 1978 Jun;85(6):594-606. doi: 10.1016/s0161-6420(78)35643-8.
3
What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).
Bull Ophthalmol Soc Egypt. 1976;69(73):469-74.
4
Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.羟苯磺酸钙治疗糖尿病视网膜病变。一项回顾性对照研究。
Ophthalmologica. 1985;190(2):102-11. doi: 10.1159/000309502.
5
Calcium dobesilate versus placebo in the treatment of diabetic retinopathy: a double-blind cross-over study.
Curr Ther Res Clin Exp. 1976 Sep;20(3):283-8.
6
The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
Diabetologia. 1977 Apr;13(2):105-9. doi: 10.1007/BF00745136.
7
A controlled clinical trial of calcium dobesylate in the treatment of diabetic retinopathy.
Diabete Metab. 1977 Mar;3(1):27-30.
8
[5 years experimentation with calcium dobesilate in the treatment of retinopathies].
Ophthalmologica. 1975;170(2-3):232-8. doi: 10.1159/000307210.
9
Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma.多贝斯（羟苯磺酸钙）可降低糖尿病性视网膜病变和青光眼患者的血液高粘滞度并降低升高的眼压。
Ophthalmic Res. 1991;23(1):12-20. doi: 10.1159/000267080.
10
Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.羟苯磺酸钙治疗糖尿病视网膜病变患者的血液高黏滞状态
Ophthalmic Res. 1985;17(3):131-8. doi: 10.1159/000265364.
引用本文的文献
1
Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial.羟苯磺酸钙治疗中国轻中度非增殖期糖尿病视网膜病变患者的疗效（CALM-DR）：一项单盲、多中心、24 臂分组随机对照临床试验方案。
BMJ Open. 2021 May 28;11(5):e045256. doi: 10.1136/bmjopen-2020-045256.
2
3
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.羟苯磺酸钙对早期糖尿病视网膜病变进展的影响：一项随机双盲研究。
Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1591-600. doi: 10.1007/s00417-006-0318-2.
4
Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.羟苯磺酸钙在慢性静脉疾病、糖尿病视网膜病变和痔疮中的安全性。
Drug Saf. 2004;27(9):649-60. doi: 10.2165/00002018-200427090-00003.
Zotero 插件